Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Gynecology

Treatment Strategies: Targeting the Cause

At a Glance

Chronic cervicitis treatment depends on its cause: confirmed infections may need targeted antibiotics, while irritation or cervical ectropion may require removing a trigger or a procedure. Repeating antibiotics when tests are negative can cause resistance and disrupt vaginal flora.

Because “chronic cervicitis” is a general term for persistent inflammation, treatment must be targeted to the specific cause. Using “empiric” antibiotics—meaning a broad-spectrum drug used based on risk or examination before a specific cause is confirmed—is sometimes appropriate and necessary [1]. However, repeated or unnecessary use of broad-spectrum drugs can lead to antibiotic resistance [2]. Your care plan should focus on pathogen-directed therapy where possible, which means treating the exact germ or irritant identified by your tests.

Important Safety Note: Never self-start, share, or repeat antibiotics without consulting your clinician. Unnecessary antibiotics can disrupt your vaginal flora and contribute to drug resistance.

Treating Infectious Causes

When an infection is confirmed or empiric treatment is justified by your risk or exam, doctors follow established guidelines to clear the pathogen and prevent the inflammation from spreading. Note that treatment choices change with pregnancy, allergies, weight, and local resistance patterns; the following are examples from current guidance.

  • Chlamydia: The standard treatment for non-pregnant adults is typically doxycycline (100 mg twice daily for 7 days) [3][4]. (Doxycycline is generally not the regimen used during pregnancy).
  • Gonorrhea: This is typically treated with a single injection of ceftriaxone. The dose is weight-based (500 mg for people under 150 kg, and 1 g for those at or above 150 kg). If chlamydia has not been ruled out, your doctor will likely add a 7-day course of doxycycline [5][4].
  • Trichomoniasis: In women, the preferred treatment is a 7-day course of metronidazole (500 mg twice daily) [6][7]. Because reinfection is very common with this parasite, it is standard to be retested about three months after treatment [7].

The Challenge of Mycoplasma genitalium

Mycoplasma genitalium (Mgen) is notoriously difficult to treat because it lacks a cell wall (making many common antibiotics useless) and has developed high levels of resistance to standard drugs [8][9].

Treatment for Mgen is now often staged and resistance-guided [10]:

  1. Doxycycline Lead-in: You will first take doxycycline for 7 days. While this rarely cures Mgen on its own, it reduces the “bacterial load,” making the second drug more effective [11][12].
  2. Targeted Follow-up: If your test shows the strain is sensitive to macrolides, you will follow the doxycycline with a multi-day course of azithromycin. If it is resistant, or if resistance testing isn’t available, you will likely take moxifloxacin for 7 days [11][13]. Moxifloxacin has important risks and contraindications that your doctor will discuss with you.

Managing Non-Infectious Causes

If your tests for infections are all negative, further antibiotics are unlikely to help and may disrupt your natural vaginal flora [14].

  • Chemical/Allergic Irritation: The primary treatment is identifying and removing the trigger, such as switching to latex-free condoms or stopping the use of scented soaps and douches [15].
  • Cervical Ectropion: If this normal tissue variation is causing severely bothersome contact bleeding or heavy discharge, and infection and cervical abnormalities have been excluded, cryotherapy (freezing the surface cells) or cautery can be an option [16]. It is not routine treatment, and watery discharge commonly persists for several weeks post-procedure [17][16].

Why Avoiding “Repeat” Antibiotics Matters

It can be tempting to request another round of antibiotics if symptoms persist, but repeated exposure to broad-spectrum drugs can cause several issues:

  • Resistance: It can make future infections much harder to treat by training bacteria to survive the drugs [18][14].
  • Flora Imbalance: Antibiotic exposure can disturb your natural vaginal flora, which may coexist with symptoms like yeast infections or Bacterial Vaginosis (BV) [14].
  • Masking Other Issues: Persistent symptoms that don’t respond to antibiotics may not be an infection at all; they may be caused by allergies, hormonal changes, or non-infectious cell changes [19][20].

If your first round of treatment doesn’t work, your doctor will consider a decision pathway that may include re-testing, checking for reinfection or adherence issues, and potentially an exam or colposcopy if indicated [20][19].

Return Precautions

Contact your clinician if you experience severe medication reactions, worsening pelvic pain, new fever, heavy bleeding, or if you are unable to keep your medication down due to vomiting.

Common questions in this guide

What treatment is used for chronic cervicitis?
Treatment depends on the cause. A confirmed infection may require an antibiotic directed at that organism, while chemical or allergic irritation is treated by removing the trigger. Cervical ectropion may be treated with cryotherapy or cautery when symptoms are severe and infection and cervical abnormalities have been excluded.
Do I need antibiotics if my cervicitis tests are negative?
Usually, additional antibiotics are unlikely to help when testing does not show an infection. Your clinician may instead look for irritation, cervical ectropion, or another cause because unnecessary antibiotics can disturb vaginal flora and promote resistance.
How is Mycoplasma genitalium treated?
Treatment often starts with seven days of doxycycline, followed by another antibiotic chosen according to resistance testing when available. A strain that remains sensitive to macrolides may be treated with azithromycin, while resistant strains or cases without testing may require moxifloxacin. Your clinician should review moxifloxacin risks and contraindications.
Why might my doctor avoid prescribing another antibiotic when symptoms continue?
Persistent symptoms do not always mean that an infection remains, and repeated broad-spectrum antibiotics can cause resistance or disrupt vaginal flora. Your clinician may retest, check for reinfection or missed doses, and consider an examination or colposcopy when appropriate.
When can cervical ectropion be treated?
Treatment may be considered when cervical ectropion causes very bothersome contact bleeding or heavy discharge after infection and cervical abnormalities have been ruled out. Cryotherapy or cautery can be options, but treatment is not routine and watery discharge may continue for several weeks afterward.
Should my sexual partner be treated if I have infectious cervicitis?
If cervicitis is caused by an infection that can pass between sexual partners, partner evaluation and treatment may be needed to reduce the chance of reinfection. Ask your clinician which partners should be evaluated based on the specific infection found.
When should I contact a clinician during chronic cervicitis treatment?
Contact your clinician for a severe medication reaction, worsening pelvic pain, new fever, or heavy bleeding. You should also seek advice if vomiting prevents you from keeping your medication down.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific infections were found in my tests, and does my treatment plan target those specific organisms?
  2. 2.If you are prescribing a broad-spectrum antibiotic, can you explain why we are choosing this over waiting for more targeted test results?
  3. 3.For my Mycoplasma genitalium treatment, are we using a 'resistance-guided' approach with doxycycline first followed by a second antibiotic?
  4. 4.If my symptoms are due to cervical ectropion, how likely is it that cryotherapy will resolve my bleeding or discharge compared to antibiotic treatment?
  5. 5.What are the side effects of moxifloxacin, and are there other options if I have concerns about its risks?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Cervicitis: Etiology, diagnosis and treatment.

    Ortiz-de la Tabla V, Gutiérrez F

    Enfermedades infecciosas y microbiologia clinica (English ed.) 2019; (37(10)):661-667 doi:10.1016/j.eimc.2018.12.004.

    PMID: 30630634
  2. 2

    Factors predicting STI-positive cervicitis and pelvic inflammatory disease, and implications on antibiotic use: a cross-sectional analysis.

    Chawla S, Varma R, Wong AKC

    Sexual health 2026; (23(2)) doi:10.1071/SH25221.

    PMID: 41866150
  3. 3

    Chlamydia trachomatis Genital Infections.

    O'Connell CM, Ferone ME

    Microbial cell (Graz, Austria) 2016; (3(9)):390-403 doi:10.15698/mic2016.09.525.

    PMID: 28357377
  4. 4

    Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020.

    St Cyr S, Barbee L, Workowski KA, et al.

    MMWR. Morbidity and mortality weekly report 2020; (69(50)):1911-1916 doi:10.15585/mmwr.mm6950a6.

    PMID: 33332296
  5. 5

    Management of Neisseria gonorrhoeae in the United States: Summary of Evidence From the Development of the 2020 Gonorrhea Treatment Recommendations and the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infection Treatment Guidelines.

    Barbee LA, St Cyr SB

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (74(Suppl_2)):S95-S111 doi:10.1093/cid/ciac043.

    PMID: 35416971
  6. 6

    Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.

    Kissinger PJ, Gaydos CA, Seña AC, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (74(Suppl_2)):S152-S161 doi:10.1093/cid/ciac030.

    PMID: 35416973
  7. 7

    Assessment and Treatment of Vaginitis.

    Mitchell CM

    Obstetrics and gynecology 2024; (144(6)):765-781 doi:10.1097/AOG.0000000000005673.

    PMID: 38991218
  8. 8

    Treatment Approaches for Refractory Mycoplasma genitalium Infection.

    Tenney R, Portillo ER, Bacic Lima D, Torres Isasiga JA

    Open forum infectious diseases 2026; (13(Suppl 2)):S1381-S1389 doi:10.1093/ofid/ofag031.

    PMID: 41918854
  9. 9

    Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis.

    Horner P, Ingle SM, Garrett F, et al.

    Sexually transmitted infections 2018; (94(1)):14-20 doi:10.1136/sextrans-2016-053060.

    PMID: 28717050
  10. 10

    Mycoplasma genitalium: Key Information for the Primary Care Clinician.

    Obafemi OA, Rowan SE, Nishiyama M, Wendel KA

    The Medical clinics of North America 2024; (108(2)):297-310 doi:10.1016/j.mcna.2023.07.004.

    PMID: 38331481
  11. 11

    Resistance-Guided Antimicrobial Therapy Using Doxycycline-Moxifloxacin and Doxycycline-2.5 g Azithromycin for the Treatment of Mycoplasma genitalium Infection: Efficacy and Tolerability.

    Durukan D, Read TRH, Murray G, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (71(6)):1461-1468 doi:10.1093/cid/ciz1031.

    PMID: 31629365
  12. 12

    Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure.

    Vodstrcil LA, Plummer EL, Doyle M, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022; (75(5)):813-823 doi:10.1093/cid/ciab1058.

    PMID: 34984438
  13. 13

    2023 Korean sexually transmitted infections treatment guidelines for Mycoplasma genitalium by KAUTII.

    Lee SJ, Choi JB, Bae S, et al.

    Investigative and clinical urology 2024; (65(1)):16-22 doi:10.4111/icu.20230314.

    PMID: 38197747
  14. 14

    Exposure to doxycycline increases risk of carrying a broad range of enteric antimicrobial resistance determinants in an elderly cohort.

    Carpenter L, Miller S, Flynn E, et al.

    The Journal of infection 2024; (89(4)):106243 doi:10.1016/j.jinf.2024.106243.

    PMID: 39142392
  15. 15

    Cervicitis aetiology and case definition: a study in Australian women attending sexually transmitted infection clinics.

    Lusk MJ, Garden FL, Rawlinson WD, et al.

    Sexually transmitted infections 2016; (92(3)):175-81 doi:10.1136/sextrans-2015-052332.

    PMID: 26586777
  16. 16

    Cryotherapy as a Method for Relieving Symptoms of Cervical Ectopy: A Randomized Clinical Trial.

    Agah J, Sharifzadeh M, Hosseinzadeh A

    Oman medical journal 2019; (34(4)):322-326 doi:10.5001/omj.2019.63.

    PMID: 31360321
  17. 17

    Is Cryotherapy Friend or Foe for Symptomatic Cervical Ectopy?

    Çekmez Y, Şanlıkan F, Göçmen A, et al.

    Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2016; (25(1)):8-11 doi:10.1159/000441433.

    PMID: 26436550
  18. 18

    The clinical indications for testing women for Mycoplasma genitalium.

    Latimer RL, Vodstrcil LA, Plummer EL, et al.

    Sexually transmitted infections 2022; (98(4)):277-285 doi:10.1136/sextrans-2020-054818.

    PMID: 34210839
  19. 19

    Congenital Transformation Zone Mimicking Cervical Premalignant Lesion.

    Dhanasekaran K, Gupta S, Ramakrishna U, Hariprasad R

    Journal of obstetrics and gynaecology of India 2021; (71(5)):557-559 doi:10.1007/s13224-020-01352-2.

    PMID: 34602771
  20. 20

    Clinical and Microbiological Profile of Recurrent and/or Persistent Cervicitis in Patients Attending Suraksha Clinic.

    Sahu A, Garg T, Kaur R, et al.

    Indian journal of dermatology 2026; (71(2)):169 doi:10.4103/ijd.ijd_658_24.

    PMID: 41884740

This page explains cause-specific treatment options for chronic cervicitis for informational purposes only and does not replace medical advice. Ask your clinician before starting, stopping, or repeating any medication.

Get notified when new evidence is published on chronic cervicitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.